{"id":"https://openalex.org/W2397477141","doi":null,"title":"Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.","display_name":"Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2397477141","mag":"2397477141","pmid":"https://pubmed.ncbi.nlm.nih.gov/17024968"},"language":"en","primary_location":{"id":"pmid:17024968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17024968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental therapeutics & oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2397477141"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036608249","display_name":"Vanitha Ramakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152047","display_name":"PDL BioPharma (United States)","ror":"https://ror.org/03ya6pd97","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152047"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vanitha Ramakrishnan","raw_affiliation_strings":["PDL Biopharma Inc, Fremont CA 94555, USA. vanitha@pdl.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PDL Biopharma Inc, Fremont CA 94555, USA. vanitha@pdl.com","institution_ids":["https://openalex.org/I4210152047"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083606763","display_name":"Vinay Bhaskar","orcid":"https://orcid.org/0000-0001-8696-3374","observed_orcids":["https://orcid.org/0000-0001-8696-3374"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vinay Bhaskar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074114064","display_name":"Debbie A. Law","orcid":"https://orcid.org/0009-0001-9977-4297","observed_orcids":["https://orcid.org/0009-0001-9977-4297"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Debbie A Law","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035805093","display_name":"Melanie H.L. Wong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melanie H L Wong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064712814","display_name":"Robert B. DuBridge","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert B DuBridge","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083090898","display_name":"Danna Breinberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Danna Breinberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064349512","display_name":"Christopher O\u2019Hara","orcid":"https://orcid.org/0000-0001-5571-5546","observed_orcids":["https://orcid.org/0000-0001-5571-5546"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher O'Hara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David B Powers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David B Powers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100682328","display_name":"Gao Liu","orcid":"https://orcid.org/0000-0002-9025-3751","observed_orcids":["https://orcid.org/0000-0002-9025-3751"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gao Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015651920","display_name":"Jennifer Grove","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Grove","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084720476","display_name":"Peter A. Hevezi","orcid":"https://orcid.org/0000-0002-1906-5846","observed_orcids":["https://orcid.org/0000-0002-1906-5846"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Hevezi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041032444","display_name":"Kellie M Cass","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kellie M Cass","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111831943","display_name":"Susan R. Watson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan Watson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027832573","display_name":"Ferdinand Evangelista","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ferdinand Evangelista","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074605478","display_name":"Rick Powers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rick A Powers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030654977","display_name":"B. Finck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Finck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053931261","display_name":"M. Wills","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Margaret Wills","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051447227","display_name":"Ingrid W. Caras","orcid":"https://orcid.org/0000-0002-8902-808X","observed_orcids":["https://orcid.org/0000-0002-8902-808X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingrid Caras","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070703779","display_name":"Yuni Fang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuni Fang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Donald McDonald","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donald McDonald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Dale Johnson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dale Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103461957","display_name":"Richard Murray","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard Murray","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032479696","display_name":"Ursula B. Jeffry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ursula Jeffry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.0206,"has_fulltext":false,"cited_by_count":129,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.92084817,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"5","issue":"4","first_page":"273","last_page":"286"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6646000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.6646000146865845,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.3328000009059906,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrin-alpha5beta1","display_name":"alpha5beta1 integrin","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/angiogenesis-inhibition","display_name":"angiogenesis inhibition","score":0.8740000128746033},{"id":"https://openalex.org/keywords/fab-fragment","display_name":"Fab fragment","score":0.753000020980835},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.8019999861717224},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.9020000100135803},{"id":"https://openalex.org/keywords/endothelial-cell-apoptosis","display_name":"endothelial cell apoptosis","score":0.8149999976158142},{"id":"https://openalex.org/keywords/tube-formation","display_name":"tube formation","score":0.6880000233650208},{"id":"https://openalex.org/keywords/choroidal-neovascularization","display_name":"choroidal neovascularization","score":0.9520000219345093},{"id":"https://openalex.org/keywords/neovessel-formation","display_name":"neovessel formation","score":0.625},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.3880000114440918}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6789113879203796},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6696245670318604},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5260260701179504},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5256137251853943},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5119293928146362},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5054128170013428},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.471407413482666},{"id":"https://openalex.org/C86492073","wikidata":"https://www.wikidata.org/wiki/Q413766","display_name":"Fibronectin","level":3,"score":0.4426501393318176},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.40156474709510803},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36315029859542847},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24249300360679626},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20783641934394836},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18341729044914246},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.15999248623847961},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.10584181547164917},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002522","descriptor_name":"Chlorocebus aethiops","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005109","descriptor_name":"Extracellular Matrix","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008268","descriptor_name":"Macular Degeneration","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019556","descriptor_name":"COS Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D039081","descriptor_name":"Integrin alpha5beta1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D039081","descriptor_name":"Integrin alpha5beta1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17024968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17024968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental therapeutics & oncology","raw_type":"Journal Article"},{"id":"mag:2397477141","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17024968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W53973778","https://openalex.org/W68397822","https://openalex.org/W120718033","https://openalex.org/W146600679","https://openalex.org/W182527921","https://openalex.org/W1552039422","https://openalex.org/W1582963778","https://openalex.org/W1679229092","https://openalex.org/W1964894126","https://openalex.org/W1984038456","https://openalex.org/W1989780564","https://openalex.org/W1992361608","https://openalex.org/W1996870435","https://openalex.org/W2000292756","https://openalex.org/W2000690578","https://openalex.org/W2000763913","https://openalex.org/W2001563940","https://openalex.org/W2001753204","https://openalex.org/W2011217812","https://openalex.org/W2012852444","https://openalex.org/W2021846668","https://openalex.org/W2030522563","https://openalex.org/W2032652443","https://openalex.org/W2041678691","https://openalex.org/W2061230824","https://openalex.org/W2070134611","https://openalex.org/W2071062791","https://openalex.org/W2074816893","https://openalex.org/W2077090481","https://openalex.org/W2086619383","https://openalex.org/W2094844458","https://openalex.org/W2096735172","https://openalex.org/W2096868396","https://openalex.org/W2098155102","https://openalex.org/W2100314556","https://openalex.org/W2112759697","https://openalex.org/W2114112168","https://openalex.org/W2118489953","https://openalex.org/W2118881364","https://openalex.org/W2124863710","https://openalex.org/W2141114204","https://openalex.org/W2142853396","https://openalex.org/W2157769714"],"related_works":["https://openalex.org/W2087851382","https://openalex.org/W2131425688","https://openalex.org/W2583711373","https://openalex.org/W2086812407","https://openalex.org/W2077090481","https://openalex.org/W2218497632","https://openalex.org/W193485848","https://openalex.org/W2062155137","https://openalex.org/W2339177627","https://openalex.org/W2410320980"],"abstract_inverted_index":{"Integrin":[0],"alpha5beta1,":[1,179],"the":[2,32,49,57,228],"principal":[3],"fibronectin":[4,77],"receptor,":[5],"is":[6,18,224],"an":[7,36,91,121,185],"important":[8],"survival":[9],"factor,":[10],"playing":[11],"a":[12,43,146,191,225],"key":[13],"role":[14],"in":[15,122,136,181,190,206,217,219],"angiogenesis.":[16],"Angiogenesis":[17],"critical":[19],"for":[20],"tumor":[21],"growth,":[22],"and":[23,55,62,74,96,114,198],"anti-angiogenic":[24],"therapies":[25],"have":[26],"met":[27],"clinical":[28],"success.":[29],"To":[30],"validate":[31],"therapeutic":[33,215],"potential":[34,83,216],"of":[35,48,76,84,102,107,120,125,148,151,158,165,184,194,203,227],"anti-alpha5beta1":[37,186],"strategy,":[38],"we":[39],"generated":[40],"volociximab":[41,95,103,113,134,162,213],"(M200)":[42],"chimeric":[44],"human":[45],"IgG4":[46],"version":[47],"alpha5beta1":[50,85,159],"function-blocking":[51],"murine":[52],"antibody":[53],"IIA1;":[54],"F200,":[56],"Fab":[58],"derivative.":[59],"Volociximab,":[60],"F200":[61,115,199],"IIA1":[63],"showed":[64],"similar":[65],"activity":[66],"by":[67,141,161],"ELISA":[68],"(EC50=":[69],"0.2nM),":[70],"Biacore":[71],"(Kd=":[72],"0.1-0.4nM)":[73],"inhibition":[75,157],"binding":[78],"(IC50=":[79],"2-3nM).":[80],"The":[81],"inhibitory":[82],"antibodies":[86],"was":[87,188],"compared":[88],"to":[89],"HuMV833,":[90],"anti-VEGF":[92],"antibody.":[93],"Both":[94],"HuMV833":[97,108],"inhibited":[98,135],"HUVEC":[99],"proliferation":[100],"(IC50":[101],"=":[104,109],"0.2-0.5nM;":[105],"IC50":[106],"45nM).":[110],"However,":[111],"IIA1,":[112],"were":[116,200],"also":[117],"potent":[118,201],"inhibitors":[119,202],"vitro":[123,137],"model":[124,193],"angiogenesis":[126],"(HUVEC":[127],"tube":[128,138],"formation":[129,139,205,223],"assay),":[130],"unlike":[131],"HuMV833.":[132],"Additionally,":[133],"induced":[140,163],"VEGF":[142],"and/or":[143],"bFGF,":[144],"suggesting":[145],"mechanism":[147],"action":[149],"independent":[150],"growth":[152],"factor":[153],"stimulus.":[154],"In":[155],"fact,":[156],"function":[160],"apoptosis":[164],"actively":[166],"proliferating,":[167],"but":[168],"not":[169,175],"resting,":[170],"endothelial":[171],"cells.":[172],"Volociximab":[173,197],"does":[174],"cross-react":[176],"with":[177],"rodent":[178],"therefore":[180],"vivo":[182],"validation":[183],"approach":[187],"conducted":[189],"cynomolgus":[192],"choroidal":[195],"revascularization.":[196],"neovessel":[204],"this":[207],"model.":[208],"These":[209],"data":[210],"demonstrate":[211],"that":[212],"has":[214],"diseases":[218],"which":[220],"new":[221],"vessel":[222],"component":[226],"pathology.":[229]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2397477141","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
